Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.

about

Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.

P2860

Q51737088-03337C02-3876-42D2-AA1B-10C52181FCEF

P2860

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q47670919

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Reduced Cerebrospinal Fluid Co ...... ents with Alzheimer's Disease.

@en

Reduced Cerebrospinal Fluid Co ...... ents with Alzheimer's Disease.

@nl

type

Item

label

Reduced Cerebrospinal Fluid Co ...... ents with Alzheimer's Disease.

@en

Reduced Cerebrospinal Fluid Co ...... ents with Alzheimer's Disease.

@nl

prefLabel

Reduced Cerebrospinal Fluid Co ...... ents with Alzheimer's Disease.

@en

Reduced Cerebrospinal Fluid Co ...... ents with Alzheimer's Disease.

@nl

P1476

Reduced Cerebrospinal Fluid Co ...... ents with Alzheimer's Disease.

@en

P2093

Anders Wallin

http://www.w3.org/2001/XMLSchema#string

Erik G Almqvist

http://www.w3.org/2001/XMLSchema#string

Jan-Ove Johansson

http://www.w3.org/2001/XMLSchema#string

Johan Svensson

http://www.w3.org/2001/XMLSchema#string

Maria Bjerke

http://www.w3.org/2001/XMLSchema#string

Ulf Andreasson

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

APOA1 polymorphism influences risk for early-onset nonfamiliar AD

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity

Mild cognitive impairment as a diagnostic entity

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.

Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity.

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

P304

1017-1026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-170226

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kaj Blennow

Per Johansson

Henrik Zetterberg

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28697566

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.

about

P2860

P2860

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921